Skip to main content
Erschienen in: Journal of Neurology 2/2014

01.02.2014 | Original Communication

‘Spinal amaurosis’ (1841). On the early contribution of Edward Hocken to the concept of neuromyelitis optica

verfasst von: S. Jarius, B. Wildemann

Erschienen in: Journal of Neurology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

While the history of classical multiple sclerosis has been extensively studied, only little is known about the early history of neuromyelitis optica (Devic’s syndrome). Here we discuss a forgotten report by Edward Octavius Hocken (1820–1845) published in The Lancet in 1841. Hocken’s report is important from a historic point of view for two reasons. Firstly, apart from a French language report by Antoine Portal, no earlier case of spinal cord inflammation and amaurosis is known. Secondly and much more importantly, Hocken, who upon his untimely death at the age of just 25 years was honoured by his contemporaries as a “precocious talent” of “very early reputation”, in that article propagated the novel concept of ‘spinal amaurosis’, i.e. the concept of acute amaurosis and spinal cord disease being pathogenetically connected. Hocken’s ideas predate Devic and Gault’s seminal works on ‘neuromyelitis optica’ by more than 50 years.
Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
1
The idea of “sympathetic connections” strikingly reminds of theories that would be put forth about 30 years later by Thomas Wharton Jones (1808–1891) and others who would ascribe the occurrence of visual disturbances in patients with spinal cord diseases to involvement of the sympathetic nervous system, which was thought to confer secondary, trophic damage to the optic nerve by compromising its blood supply [43]. It is possible that Hocken was aware of Jakob Henle’s (1809–1885) and Benedict Stilling’s (1810–1889) seminal works on the vasomotor system, which had appeared the year before, i.e. in 1840. However, Hocken’s article predates the important discoveries of Claude Bernard (1813–1878) and Charles-Édouard Brown-Séquard (1817–1894) on that topic by a decade [1]. It should not go unmentioned that Allbutt would use a similar wording in his famous 1870 lecture On the ophthalmoscopic signs of spinal cord disease, where he mentioned a patient with acute myelitis and a “sympathetic eye disorder”, which until very recently was considered the first account of NMO [3]. However, it seems that Allbutt, who strongly opposed Wharton Jones’s theory, used the term ‘sympathetic’ here in a more general sense, i.e. to refer to “[a] disorder induced in a person, or in an organ or part of the body, by a similar or corresponding one in another” (Oxford English Dictionary, 2nd Edition, 1989) [3].
 
Literatur
2.
Zurück zum Zitat Akman-Demir G, Tuzun E, Waters P, Icoz S, Kurtuncu M, Jarius S, Yapici Z, Mutlu M, Yesilot N, Vincent A, Eraksoy M (2010) Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients. J Neurol 258:464–470CrossRefPubMed Akman-Demir G, Tuzun E, Waters P, Icoz S, Kurtuncu M, Jarius S, Yapici Z, Mutlu M, Yesilot N, Vincent A, Eraksoy M (2010) Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients. J Neurol 258:464–470CrossRefPubMed
3.
Zurück zum Zitat Allbutt TC (1870) On the ophthalmoscopic signs of spinal disease. Lancet 95:76–78CrossRef Allbutt TC (1870) On the ophthalmoscopic signs of spinal disease. Lancet 95:76–78CrossRef
4.
Zurück zum Zitat Anonymous (1846) The London medical directory. John Churchill, London Anonymous (1846) The London medical directory. John Churchill, London
5.
Zurück zum Zitat Chambers WF (1846) An address delievered before the Royal Medical and Chirurgical Society of London, at the Anniversary Meeting, held on Monday, March 2nd. Lancet 47:291–294CrossRef Chambers WF (1846) An address delievered before the Royal Medical and Chirurgical Society of London, at the Anniversary Meeting, held on Monday, March 2nd. Lancet 47:291–294CrossRef
6.
Zurück zum Zitat Chang KH, Lyu RK, Chen CM, Wu YR, Chang HS, Huang CC, Kuo HC, Chu CC, Hsu WC, Ro LS (2013) Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-aquaporin 4 antibodies. Mult Scler 19:299–307CrossRefPubMed Chang KH, Lyu RK, Chen CM, Wu YR, Chang HS, Huang CC, Kuo HC, Chu CC, Hsu WC, Ro LS (2013) Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-aquaporin 4 antibodies. Mult Scler 19:299–307CrossRefPubMed
7.
Zurück zum Zitat Devic E (1895) Myélite aiguë dorso-lombaire avec névrite optique—Autopsie. In: Congrès français de médecine (Premiere Session; Lyon, 1894; Procès-verbaux, mémoires et discussions; Publiés par M. le Dr L. Bard). Asselin et Houzeau, Louis Savy, Lyon, pp 434–439 Devic E (1895) Myélite aiguë dorso-lombaire avec névrite optique—Autopsie. In: Congrès français de médecine (Premiere Session; Lyon, 1894; Procès-verbaux, mémoires et discussions; Publiés par M. le Dr L. Bard). Asselin et Houzeau, Louis Savy, Lyon, pp 434–439
8.
Zurück zum Zitat Erb W (1880) Ueber das Zusammenvorkommen von Neuritis optica und Myelitis subacuta. Archiv für Psychiatrie und Nervenkrankheiten 10:146–157CrossRef Erb W (1880) Ueber das Zusammenvorkommen von Neuritis optica und Myelitis subacuta. Archiv für Psychiatrie und Nervenkrankheiten 10:146–157CrossRef
9.
Zurück zum Zitat Gault F (1894) De la neuromyélite optique aiguë. Thése. Faculté de Médecine et de Pharmacie, Lyon Gault F (1894) De la neuromyélite optique aiguë. Thése. Faculté de Médecine et de Pharmacie, Lyon
10.
Zurück zum Zitat Hocken E (1841) Illustrations of the pathology and treatment of the amauroses. Amaurosis from affections of the spinal cord or its membranes. London Medical Gazette 707. XXVIII. New Series. Vol. II. For the session 1840–41:499–504 Hocken E (1841) Illustrations of the pathology and treatment of the amauroses. Amaurosis from affections of the spinal cord or its membranes. London Medical Gazette 707. XXVIII. New Series. Vol. II. For the session 1840–41:499–504
11.
Zurück zum Zitat Hocken EO (1844) A complete condensed practical treatise on ophthalmic medicine. Part 1. Samuel Highley, London Hocken EO (1844) A complete condensed practical treatise on ophthalmic medicine. Part 1. Samuel Highley, London
12.
Zurück zum Zitat Hocken EO (1841–42) Illustrations of the pathology, diagnosis, and treatment of ophthalmic affections. Lancet 37:349–352; 636–639 Hocken EO (1841–42) Illustrations of the pathology, diagnosis, and treatment of ophthalmic affections. Lancet 37:349–352; 636–639
13.
Zurück zum Zitat Hocken EO (1842) Illustrations of the pathology, diagnosis, and treatment of ophthalmic affections. Lancet 38:81–84CrossRef Hocken EO (1842) Illustrations of the pathology, diagnosis, and treatment of ophthalmic affections. Lancet 38:81–84CrossRef
14.
Zurück zum Zitat Hocken EO (1841) Illustrations on the pathology and treatment of amaurosis. Lancet 36:38–42; 153–157; 223–225; 357–361; 470–474; 534–537; 713–716; 775–779; 916–919CrossRef Hocken EO (1841) Illustrations on the pathology and treatment of amaurosis. Lancet 36:38–42; 153–157; 223–225; 357–361; 470–474; 534–537; 713–716; 775–779; 916–919CrossRef
15.
Zurück zum Zitat Hocken EO (1841) Illustrations on the pathology and treatment of amaurosis. Part IV. Amaurosis from affections of the spinal cord or its membranes. Lancet 36:470–474CrossRef Hocken EO (1841) Illustrations on the pathology and treatment of amaurosis. Part IV. Amaurosis from affections of the spinal cord or its membranes. Lancet 36:470–474CrossRef
16.
Zurück zum Zitat Hocken EO (1841) On the diagnosis, pathology, and treatment of amaurosis. Lancet 36:7–10CrossRef Hocken EO (1841) On the diagnosis, pathology, and treatment of amaurosis. Lancet 36:7–10CrossRef
17.
Zurück zum Zitat Hocken EO (1842) A treatise on amaurosis and amaurotic affections. A. Waldie, Philadeliphia Hocken EO (1842) A treatise on amaurosis and amaurotic affections. A. Waldie, Philadeliphia
18.
Zurück zum Zitat Hocken EO (1840) A treatise on amaurosis and amaurotic affections. S. Highley, London Hocken EO (1840) A treatise on amaurosis and amaurotic affections. S. Highley, London
20.
Zurück zum Zitat Jarius S, Jacobi C, de Seze J, Zephir H, Paul F, Franciotta D, Rommer P, Mader S, Kleiter I, Reindl M, Akman-Demir G, Seifert-Held T, Kristoferitsch W, Melms A, Wandinger KP, Wildemann B (2011) Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler 17:1067–1073CrossRefPubMed Jarius S, Jacobi C, de Seze J, Zephir H, Paul F, Franciotta D, Rommer P, Mader S, Kleiter I, Reindl M, Akman-Demir G, Seifert-Held T, Kristoferitsch W, Melms A, Wandinger KP, Wildemann B (2011) Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler 17:1067–1073CrossRefPubMed
21.
Zurück zum Zitat Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B (2008) Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4:202–214PubMed Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B (2008) Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4:202–214PubMed
22.
Zurück zum Zitat Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, Ziemann U, Kern P, Wandinger KP, Then Bergh F, Boettcher T, Langel S, Liebetrau M, Rommer PS, Niehaus S, Munch C, Winkelmann A, Zettl UK, Metz I, Veauthier C, Sieb JP, Wilke C, Hartung HP, Aktas O, Paul F (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflamm 9:14CrossRef Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, Ziemann U, Kern P, Wandinger KP, Then Bergh F, Boettcher T, Langel S, Liebetrau M, Rommer PS, Niehaus S, Munch C, Winkelmann A, Zettl UK, Metz I, Veauthier C, Sieb JP, Wilke C, Hartung HP, Aktas O, Paul F (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflamm 9:14CrossRef
23.
Zurück zum Zitat Jarius S, Wandinger KP, Borowski K, Stoecker W, Wildemann B (2012) Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature. Clin Neurol Neurosurg 114:331–335CrossRefPubMed Jarius S, Wandinger KP, Borowski K, Stoecker W, Wildemann B (2012) Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature. Clin Neurol Neurosurg 114:331–335CrossRefPubMed
24.
Zurück zum Zitat Jarius S, Wildemann B (2010) AQP4 antibodies in neuromyelitis optica: pathogenic and diagnostic relevance. Nat Rev Neurol 6:383–392CrossRefPubMed Jarius S, Wildemann B (2010) AQP4 antibodies in neuromyelitis optica: pathogenic and diagnostic relevance. Nat Rev Neurol 6:383–392CrossRefPubMed
25.
Zurück zum Zitat Jarius S, Wildemann B (2013) Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol 23:661–683CrossRefPubMed Jarius S, Wildemann B (2013) Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol 23:661–683CrossRefPubMed
26.
Zurück zum Zitat Jarius S, Wildemann B (2012) The case of the Marquis de Causan (1804): an early account of visual loss associated with spinal cord inflammation. J Neurol 259:1354–1357CrossRefPubMed Jarius S, Wildemann B (2012) The case of the Marquis de Causan (1804): an early account of visual loss associated with spinal cord inflammation. J Neurol 259:1354–1357CrossRefPubMed
27.
Zurück zum Zitat Jarius S, Wildemann B (2012) An early British case of neuromyelitis optica (1850). BMJ 345:e6430CrossRefPubMed Jarius S, Wildemann B (2012) An early British case of neuromyelitis optica (1850). BMJ 345:e6430CrossRefPubMed
28.
Zurück zum Zitat Jarius S, Wildemann B (2011) An early case of neuromyelitis optica: on a forgotten report by Jacob Lockhart Clarke, FRS. Mult Scler 17:1384–1386CrossRefPubMed Jarius S, Wildemann B (2011) An early case of neuromyelitis optica: on a forgotten report by Jacob Lockhart Clarke, FRS. Mult Scler 17:1384–1386CrossRefPubMed
29.
Zurück zum Zitat Jarius S, Wildemann B (2013) The history of neuromyelitis optica. J Neuroinflamm 10:8CrossRef Jarius S, Wildemann B (2013) The history of neuromyelitis optica. J Neuroinflamm 10:8CrossRef
30.
Zurück zum Zitat Jarius S, Wildemann B (2012) ‘Noteomielite’ accompanied by acute amaurosis (1844). An early case of neuromyelitis optica. J Neurol Sci 313:182–184CrossRefPubMed Jarius S, Wildemann B (2012) ‘Noteomielite’ accompanied by acute amaurosis (1844). An early case of neuromyelitis optica. J Neurol Sci 313:182–184CrossRefPubMed
31.
Zurück zum Zitat Jarius S, Wildemann B (2013) On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica. J Neurol 260:100–104CrossRefPubMed Jarius S, Wildemann B (2013) On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica. J Neurol 260:100–104CrossRefPubMed
32.
Zurück zum Zitat Kitley J, Woodhall M, Waters P, Leite MI, Devenney E, Craig J, Palace J, Vincent A (2012) Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79:1273–1277CrossRefPubMed Kitley J, Woodhall M, Waters P, Leite MI, Devenney E, Craig J, Palace J, Vincent A (2012) Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79:1273–1277CrossRefPubMed
33.
Zurück zum Zitat Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473–477PubMedCentralCrossRefPubMed Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473–477PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112CrossRefPubMed Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112CrossRefPubMed
35.
Zurück zum Zitat Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A, Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H, Deisenhammer F, Aboul-Enein F, Storch MK, Koson P, Drulovic J, Kristoferitsch W, Berger T, Reindl M (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflamm 8:184CrossRef Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A, Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H, Deisenhammer F, Aboul-Enein F, Storch MK, Koson P, Drulovic J, Kristoferitsch W, Berger T, Reindl M (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflamm 8:184CrossRef
36.
Zurück zum Zitat Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65:78–83PubMed Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65:78–83PubMed
37.
Zurück zum Zitat Portal A (1804) Cours d’anatomie médicale, ou éléments de l’anatomie de l’homme. Avec des remarques physiologiques et pathologiques, et les résultats de l’observation sur le siége et la nature des maladies, d’après l’ouverture des corps Baudoin, Laport, Bertrand, Paris Portal A (1804) Cours d’anatomie médicale, ou éléments de l’anatomie de l’homme. Avec des remarques physiologiques et pathologiques, et les résultats de l’observation sur le siége et la nature des maladies, d’après l’ouverture des corps Baudoin, Laport, Bertrand, Paris
38.
Zurück zum Zitat Rostasy K, Mader S, Hennes E, Schanda K, Gredler V, Guenther A, Blaschek A, Korenke C, Pritsch M, Pohl D, Maier O, Kuchukhidze G, Brunner-Krainz M, Berger T, Reindl M (2012) Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler 19:1052–1059CrossRefPubMed Rostasy K, Mader S, Hennes E, Schanda K, Gredler V, Guenther A, Blaschek A, Korenke C, Pritsch M, Pohl D, Maier O, Kuchukhidze G, Brunner-Krainz M, Berger T, Reindl M (2012) Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler 19:1052–1059CrossRefPubMed
39.
Zurück zum Zitat Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, Du Pasquier RA, Polman CH, Sorensen PS, Hemmer B (2010) EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 17:1019–1032CrossRefPubMed Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, Du Pasquier RA, Polman CH, Sorensen PS, Hemmer B (2010) EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 17:1019–1032CrossRefPubMed
40.
Zurück zum Zitat Sellner J, Hemmer B, Muhlau M (2010) The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J Autoimmun 34:371–379CrossRefPubMed Sellner J, Hemmer B, Muhlau M (2010) The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J Autoimmun 34:371–379CrossRefPubMed
41.
Zurück zum Zitat Trebst C, Jarius S, Berthele A, Paul F, Schippling S, Wildemann B, Borisow N, Kleiter I, Aktas O, Kümpfel T; Neuromyelitis Optica Study Group (NEMOS) (2013) Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol 261:1–16 Trebst C, Jarius S, Berthele A, Paul F, Schippling S, Wildemann B, Borisow N, Kleiter I, Aktas O, Kümpfel T; Neuromyelitis Optica Study Group (NEMOS) (2013) Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol 261:1–16
42.
Zurück zum Zitat Wandinger KP, Stangel M, Witte T, Venables P, Charles P, Jarius S, Wildemann B, Probst C, Iking-Konert C, Schneider M (2010) Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjogren’s syndrome. Arthritis Rheum 62:1198–1200CrossRefPubMed Wandinger KP, Stangel M, Witte T, Venables P, Charles P, Jarius S, Wildemann B, Probst C, Iking-Konert C, Schneider M (2010) Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjogren’s syndrome. Arthritis Rheum 62:1198–1200CrossRefPubMed
43.
Zurück zum Zitat Wharton-Jones T (1869) Failure of sight from railway and other injuries of the spine and head. With a physiological and pathological disquisition into the influence of the vaso-motor nerves on the circulation of the blood in the extreme vessels. Bradbury, Evans, and Co., London Wharton-Jones T (1869) Failure of sight from railway and other injuries of the spine and head. With a physiological and pathological disquisition into the influence of the vaso-motor nerves on the circulation of the blood in the extreme vessels. Bradbury, Evans, and Co., London
44.
Zurück zum Zitat Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 53:1107–1114CrossRefPubMed Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 53:1107–1114CrossRefPubMed
45.
Zurück zum Zitat Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805–815CrossRefPubMed Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805–815CrossRefPubMed
46.
Zurück zum Zitat Yang Y, Huang DH, Wu WP, Wu L, Chen LF, Wu Q (2013) The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica. J Clin Neurosci 20:94–98CrossRefPubMed Yang Y, Huang DH, Wu WP, Wu L, Chen LF, Wu Q (2013) The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica. J Clin Neurosci 20:94–98CrossRefPubMed
47.
Zurück zum Zitat Yoshimura S, Isobe N, Matsushita T, Yonekawa T, Masaki K, Sato S, Kawano Y, Kira J (2013) Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status. J Neurol Neurosurg Psychiatry 84:29–34CrossRefPubMed Yoshimura S, Isobe N, Matsushita T, Yonekawa T, Masaki K, Sato S, Kawano Y, Kira J (2013) Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status. J Neurol Neurosurg Psychiatry 84:29–34CrossRefPubMed
48.
Zurück zum Zitat Závada J, Nytrová P, Wandinger KP, Jarius S, Svobodová R, Probst C, Peterová V, Tegzová D, Pavelka K, Vencovský J (2013) Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus. Rheumatol Int 33:259–263 Závada J, Nytrová P, Wandinger KP, Jarius S, Svobodová R, Probst C, Peterová V, Tegzová D, Pavelka K, Vencovský J (2013) Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus. Rheumatol Int 33:259–263
Metadaten
Titel
‘Spinal amaurosis’ (1841). On the early contribution of Edward Hocken to the concept of neuromyelitis optica
verfasst von
S. Jarius
B. Wildemann
Publikationsdatum
01.02.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 2/2014
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-013-7210-x

Weitere Artikel der Ausgabe 2/2014

Journal of Neurology 2/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.